Cytokinetics
CYTK
#2088
Rank
A$13.70 B
Marketcap
A$100.95
Share price
1.75%
Change (1 day)
94.58%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2026 (TTM): -A$1.24 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are A$0.10 Billion. In 2025 the company made an earning of -A$1.12 Billion a decrease over its 2024 earnings that were of -A$0.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.24 Billion11.55%
2025 -A$1.12 Billion33.15%
2024 -A$0.84 Billion12.03%
2023 -A$0.75 Billion35.3%
2022 -A$0.56 Billion80.65%
2021 -A$0.31 Billion69.15%
2020 -A$0.19 Billion4.6%
2019 -A$0.18 Billion14.49%
2018 -A$0.16 Billion-16.83%
2017 -A$0.19 Billion-812.8%
2016 A$25.35 M-147.81%
2015 -A$53.04 Million156.05%
2014 -A$20.72 Million-56.56%
2013 -A$47.69 Million-16.48%
2012 -A$57.1 Million-15.65%
2011 -A$67.69 Million-3.24%
2010 -A$69.96 Million-308.68%
2009 A$33.52 M-141.87%
2008 -A$80.06 Million0.21%
2007 -A$79.89 Million-7.91%
2006 -A$86.76 Million37.42%
2005 -A$63.13 Million16.13%
2004 -A$54.36 Million-19.29%
2003 -A$67.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.85 B-1,195.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-A$43.93 Million-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.23 B-119.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.39 Billion-67.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-A$2.67 Million-99.77%๐Ÿ‡บ๐Ÿ‡ธ USA